Cargando…

Benzodiazepine use, misuse, and abuse: A review

Benzodiazepine (BZD) abuse has reached epidemic levels and results in poor outcomes, particularly when combined with concomitant central nervous system depressants. BZDs are abused most commonly in combination with opioids and alcohol. Emergency department visits and related deaths have soared in re...

Descripción completa

Detalles Bibliográficos
Autor principal: Schmitz, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007645/
https://www.ncbi.nlm.nih.gov/pubmed/29955458
http://dx.doi.org/10.9740/mhc.2016.05.120
_version_ 1783333075259752448
author Schmitz, Allison
author_facet Schmitz, Allison
author_sort Schmitz, Allison
collection PubMed
description Benzodiazepine (BZD) abuse has reached epidemic levels and results in poor outcomes, particularly when combined with concomitant central nervous system depressants. BZDs are abused most commonly in combination with opioids and alcohol. Emergency department visits and related deaths have soared in recent years. In the absence of other medications or illicit substances, BZDs are rarely the sole cause of death. Prescription drug abuse has received more attention in recent years, yet much remains unknown about BZD abuse. BZDs have low abuse potential in most of the general population. A subset is at elevated risk of abuse, especially those with a history of a substance use disorder. Education, prevention, and identification are vital in reducing BZD abuse.
format Online
Article
Text
id pubmed-6007645
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher College of Psychiatric & Neurologic Pharmacists
record_format MEDLINE/PubMed
spelling pubmed-60076452018-06-28 Benzodiazepine use, misuse, and abuse: A review Schmitz, Allison Ment Health Clin Addictive Disorder Treatments Benzodiazepine (BZD) abuse has reached epidemic levels and results in poor outcomes, particularly when combined with concomitant central nervous system depressants. BZDs are abused most commonly in combination with opioids and alcohol. Emergency department visits and related deaths have soared in recent years. In the absence of other medications or illicit substances, BZDs are rarely the sole cause of death. Prescription drug abuse has received more attention in recent years, yet much remains unknown about BZD abuse. BZDs have low abuse potential in most of the general population. A subset is at elevated risk of abuse, especially those with a history of a substance use disorder. Education, prevention, and identification are vital in reducing BZD abuse. College of Psychiatric & Neurologic Pharmacists 2016-05-06 /pmc/articles/PMC6007645/ /pubmed/29955458 http://dx.doi.org/10.9740/mhc.2016.05.120 Text en © 2016 CPNP. http://creativecommons.org/licenses/by-nc/3.0/ The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Addictive Disorder Treatments
Schmitz, Allison
Benzodiazepine use, misuse, and abuse: A review
title Benzodiazepine use, misuse, and abuse: A review
title_full Benzodiazepine use, misuse, and abuse: A review
title_fullStr Benzodiazepine use, misuse, and abuse: A review
title_full_unstemmed Benzodiazepine use, misuse, and abuse: A review
title_short Benzodiazepine use, misuse, and abuse: A review
title_sort benzodiazepine use, misuse, and abuse: a review
topic Addictive Disorder Treatments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007645/
https://www.ncbi.nlm.nih.gov/pubmed/29955458
http://dx.doi.org/10.9740/mhc.2016.05.120
work_keys_str_mv AT schmitzallison benzodiazepineusemisuseandabuseareview